Dixon Mitchell Investment Counsel Inc. decreased its holdings in shares of AMETEK, Inc. (NYSE:AME - Free Report) by 1.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 383,607 shares of the technology company's stock after selling 6,721 shares during the quarter. AMETEK accounts for approximately 3.2% of Dixon Mitchell Investment Counsel Inc.'s portfolio, making the stock its 10th largest position. Dixon Mitchell Investment Counsel Inc. owned about 0.17% of AMETEK worth $69,149,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of AME. Itau Unibanco Holding S.A. boosted its holdings in shares of AMETEK by 62.6% in the 3rd quarter. Itau Unibanco Holding S.A. now owns 200 shares of the technology company's stock worth $34,000 after purchasing an additional 77 shares in the last quarter. Versant Capital Management Inc lifted its position in AMETEK by 3,116.7% in the 4th quarter. Versant Capital Management Inc now owns 193 shares of the technology company's stock worth $35,000 after buying an additional 187 shares during the last quarter. AdvisorNet Financial Inc boosted its stake in AMETEK by 1,176.5% in the fourth quarter. AdvisorNet Financial Inc now owns 217 shares of the technology company's stock worth $39,000 after buying an additional 200 shares in the last quarter. Princeton Global Asset Management LLC bought a new position in AMETEK during the third quarter valued at approximately $44,000. Finally, Anchor Investment Management LLC raised its stake in shares of AMETEK by 366.1% during the third quarter. Anchor Investment Management LLC now owns 261 shares of the technology company's stock worth $45,000 after acquiring an additional 205 shares in the last quarter. 87.43% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other AMETEK news, insider Emanuela Speranza sold 6,747 shares of the company's stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $195.90, for a total transaction of $1,321,737.30. Following the transaction, the insider now owns 30,460 shares in the company, valued at approximately $5,967,114. This represents a 18.13 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Tony J. Ciampitti sold 16,210 shares of the firm's stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $197.01, for a total value of $3,193,532.10. Following the completion of the transaction, the insider now owns 49,490 shares of the company's stock, valued at approximately $9,750,024.90. The trade was a 24.67 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 29,200 shares of company stock valued at $5,707,620 over the last three months. Corporate insiders own 0.61% of the company's stock.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on AME. Wolfe Research raised shares of AMETEK to a "hold" rating in a research note on Wednesday, September 18th. TD Cowen lowered shares of AMETEK from a "hold" rating to a "sell" rating in a research report on Monday, October 7th. Mizuho lifted their price objective on AMETEK from $190.00 to $200.00 and gave the stock an "outperform" rating in a report on Friday, November 1st. StockNews.com raised AMETEK from a "hold" rating to a "buy" rating in a research note on Thursday, January 9th. Finally, KeyCorp raised their price target on AMETEK from $205.00 to $215.00 and gave the stock an "overweight" rating in a research report on Friday, November 22nd. One investment analyst has rated the stock with a sell rating, two have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $203.44.
View Our Latest Report on AMETEK
AMETEK Trading Up 0.5 %
NYSE AME traded up $0.83 on Thursday, hitting $180.89. The company's stock had a trading volume of 1,698,871 shares, compared to its average volume of 966,617. The company has a current ratio of 1.39, a quick ratio of 0.84 and a debt-to-equity ratio of 0.18. AMETEK, Inc. has a 52-week low of $149.03 and a 52-week high of $198.33. The firm has a market cap of $41.84 billion, a P/E ratio of 31.51, a PEG ratio of 2.51 and a beta of 1.16. The company's 50-day simple moving average is $187.54 and its 200 day simple moving average is $174.98.
AMETEK (NYSE:AME - Get Free Report) last announced its quarterly earnings results on Thursday, October 31st. The technology company reported $1.66 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.04. The company had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.71 billion. AMETEK had a return on equity of 16.88% and a net margin of 19.27%. The firm's revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.64 earnings per share. Research analysts predict that AMETEK, Inc. will post 6.8 EPS for the current fiscal year.
AMETEK Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, December 20th. Investors of record on Friday, December 6th were given a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 0.62%. The ex-dividend date was Friday, December 6th. AMETEK's dividend payout ratio is currently 19.51%.
AMETEK Profile
(
Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Read More
Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report